Evidence map›Paper›PMID 41552670›Full record

ArticleIJTLD open2026

Treatment and outcomes in patients with non-TB mycobacterial pulmonary disease: a single-centre study.

V N Dahl, A Fløe, F Rudolf, J van Ingen, A B Andersen, T Lillebaek, C M Wejse

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJTLD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

V N DahlDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
A FløeDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
F RudolfDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
J van IngenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
A B AndersenDepartment of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
T LillebaekInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
C M WejseDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Denmark, information on treatment and outcomes of non-TB mycobacterial pulmonary disease (NTM-PD) are limited. We aimed to evaluate treatment and clinical outcomes in patients with pulmonary NTM isolates.

methodsWe conducted a retrospective cohort study of all patients with pulmonary NTM isolates, except

resultsAmong 164 patients (median age 70 years; 48.1% male), 54.3% received antibiotic therapy, and 30% of patients meeting diagnostic criteria were not treated. Most treated patients (87.6%) were prescribed an ethambutol-macrolide-rifamycin regimen; few received intravenous (

conclusionTo improve outcomes for NTM-PD patients, improved microbiological monitoring, guideline adherence, individualised therapy for high-risk patients, consideration of prolonged or intensified therapy, and better treatment regimens are needed.

Indexed as

DenmarkmortalityNTMoutcomespulmonary infectiontreatmenttuberculosis

Identifiers

PMID41552670
PMCPMC12810752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.